382 related articles for article (PubMed ID: 36198377)
1. Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis.
Ai G; Huang R; Xie J; Zhong L; Wu X; Qin Z; Su Z; Chen J; Yang X; Dou Y
J Ethnopharmacol; 2023 Jan; 301():115775. PubMed ID: 36198377
[TBL] [Abstract][Full Text] [Related]
2. Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice.
Lu M; Yin J; Xu T; Dai X; Liu T; Zhang Y; Wang S; Liu Y; Shi H; Zhang Y; Mo F; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117262. PubMed ID: 37788785
[TBL] [Abstract][Full Text] [Related]
3.
Chen J; Xu L; Jiang L; Wu Y; Wei L; Wu X; Xiao S; Liu Y; Gao C; Cai J; Su Z
Food Funct; 2021 Oct; 12(19):9416-9431. PubMed ID: 34606558
[No Abstract] [Full Text] [Related]
4. Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice.
Zhang Y; Wang S; Dai X; Liu T; Liu Y; Shi H; Yin J; Xu T; Zhang Y; Zhao D; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D
J Ethnopharmacol; 2023 Aug; 312():116530. PubMed ID: 37098372
[TBL] [Abstract][Full Text] [Related]
5. Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model.
Li Q; Huang Z; Liu D; Zheng J; Xie J; Chen J; Zeng H; Su Z; Li Y
Drug Des Devel Ther; 2021; 15():3241-3254. PubMed ID: 34349501
[TBL] [Abstract][Full Text] [Related]
6. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
[TBL] [Abstract][Full Text] [Related]
7. Oxyberberrubine, a novel liver microsomes-mediated secondary metabolite of berberine, alleviates hyperuricemic nephropathy in mice.
Zhong L; Lin Y; Gong S; Wu X; Liu Y; Chen J; Li Y; Yan F; Su Z; Xie Q
Phytomedicine; 2023 Jan; 108():154521. PubMed ID: 36334387
[TBL] [Abstract][Full Text] [Related]
8. Astaxanthin attenuated hyperuricemia and kidney inflammation by inhibiting uric acid synthesis and the NF-κ B/NLRP3 signaling pathways in potassium oxonate and hypoxanthine-induced hyperuricemia mice.
Zhuang J; Zhou X; Liu T; Zhang S; Yuan F; Zhang L; Yang Z; Chen Y
Pharmazie; 2021 Nov; 76(11):551-558. PubMed ID: 34782040
[TBL] [Abstract][Full Text] [Related]
9. Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice.
Xu L; Lin G; Yu Q; Li Q; Mai L; Cheng J; Xie J; Liu Y; Su Z; Li Y
Front Pharmacol; 2021; 12():645879. PubMed ID: 33959014
[TBL] [Abstract][Full Text] [Related]
10. Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice.
Xu L; Cheng J; Lu J; Lin G; Yu Q; Li Y; Chen J; Xie J; Su Z; Zhou Q
Front Pharmacol; 2022; 13():964593. PubMed ID: 36438835
[TBL] [Abstract][Full Text] [Related]
11. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice.
Wang R; Ma CH; Zhou F; Kong LD
Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200
[TBL] [Abstract][Full Text] [Related]
12. Data mining-guided alleviation of hyperuricemia by Paeonia veitchii Lynch through inhibition of xanthine oxidase and regulation of renal urate transporters.
Du J; Wang N; Yu D; He P; Gao Y; Tu Y; Li Y
Phytomedicine; 2024 Feb; 124():155305. PubMed ID: 38176275
[TBL] [Abstract][Full Text] [Related]
13. Uric acid-lowering effect of harpagoside and its protective effect against hyperuricemia-induced renal injury in mice.
Fu Q; Zhang JJ; Zhu QF; Yu LL; Wang F; Li J; He X; Ao JL; Xu GB; Wei MC; Liao XJ; Liao SG
Biochem Biophys Res Commun; 2024 Jul; 716():150038. PubMed ID: 38704891
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells.
Zhou H; Liu Y; Su Y; Ji P; Kong L; Sun R; Zhang D; Xu H; Li W; Li W
J Ethnopharmacol; 2024 Apr; 324():117794. PubMed ID: 38244950
[TBL] [Abstract][Full Text] [Related]
15. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption.
Cui D; Liu S; Tang M; Lu Y; Zhao M; Mao R; Wang C; Yuan Y; Li L; Chen Y; Cheng J; Lu Y; Liu J
Phytomedicine; 2020 Jan; 66():153111. PubMed ID: 31790902
[TBL] [Abstract][Full Text] [Related]
16. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S
Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683
[TBL] [Abstract][Full Text] [Related]
17. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
Zhou M; Li S; Song L; Hu Q; Liu W
Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
[TBL] [Abstract][Full Text] [Related]
18. [Study on mechanism of Fangji Huangqi Decoction on hypouricemic effect and renal protection in hyperuricemia mice].
Xing W; Ning X; Hong-Lei LI; Zhen C; Wan YU
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5248-5255. PubMed ID: 33350242
[TBL] [Abstract][Full Text] [Related]
19. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice.
Yang Y; Zhang DM; Liu JH; Hu LS; Xue QC; Ding XQ; Kong LD
J Ethnopharmacol; 2015 Jul; 169():49-59. PubMed ID: 25914040
[TBL] [Abstract][Full Text] [Related]
20. Sanghuangporus vaninii ethanol extract alleviates hyperuricemic renal injury by regulating the uric acid transporters and inhibiting HK-2 apoptosis.
Hua L; Zhang S; Yang J; Zhou X; Shi S
Biomed Pharmacother; 2023 Aug; 164():114970. PubMed ID: 37279627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
